OMCL NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Omnicell Inc · Healthcare · Health Information Services

Open interactive chart View report data
Latest close 35.37 USD
-13.7% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -13.7% below the Trend Line and sits at 24.3% of its 52-week range. The latest completed week returned -13.7%, after a -17.8% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is neither clearly cheap nor expensive. Options positioning is bullish with 58/100 conviction, while the latest news-sentiment score is 54/100.

Setup score 31 out of 100
Latest Close 35.37 USD 31 Jul 2026
1W Return -13.7% latest completed week
4W Return -17.8% short-term follow-through
12W Return -19.3% quarterly tape
Trend Breadth 40.4% 21 of 52 weeks active
Volume Ratio 1.8x vs 13-week average
What is working
  • Activity pressure is positive on the latest completed week.
  • Volume is elevated versus the 13-week average, confirming attention.
  • Activity pressure is constructive, supporting the smart-money activity read.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • The share remains more than 20% below its 52-week high.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -13.7% Latest completed week; four-week move -17.8%. Indicator stack 22/52 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Bullish 58/100 conviction; expected move 13.1%. News sentiment 54/100 48 relevant articles in the latest sentiment read. Event risk 30 Jul Latest stored earnings date was 30 Jul 2026.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -13.7% below the Trend Line and sits at 24.3% of its 52-week range. The latest completed week returned -13.7%, after a -17.8% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.8x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.6612-week average 0.48

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership6/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.66Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -17.8% over four weeks, -19.3% over 12 weeks, and 18.9% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-13.7%
4W-17.8%
12W-19.3%
26W-27.1%
52W18.9%
Active trend streak0 weeks
Active weeks in one year21
Trend breadth40.4%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.28Latest activity-pressure read.
Pressure change-37.2%Four-week change in activity pressure.
Leadership-15.74Latest relative-leadership reading.
RS change-22251.5%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 97% Model confidence 93%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength49/100Blend of value, momentum, and quality. Underlying universe rank 52; rank 1 is best.
Value22/100Relative valuation strength. Underlying universe rank 79; rank 1 is best.
Quality66/100Profitability and accounting quality. Underlying universe rank 35; rank 1 is best.
Momentum84/100Medium-term price momentum. Underlying universe rank 17; rank 1 is best.
Growth7/100Revenue and earnings growth. Underlying universe rank 94; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework26/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
91.3x
Price divided by trailing earnings.
Price / sales
1.5x
Market value relative to trailing revenue.
EV / EBITDA
14.2x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
11.3%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
43.5%
Gross profit retained from each unit of revenue.
Operating margin
3.4%
Operating profit retained from revenue.
Free-cash-flow margin
16.3%
Free cash flow generated from revenue.
Return on invested capital
1.9%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
7.9%
Latest one-year revenue growth.
EPS growth
-3.5%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-5.1%
Latest one-year free-cash-flow growth.
Piotroski F-score
6/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
3.3%
Net share repurchases relative to market value.
Shareholder yield
3.3%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-0.7x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBullish

OMCL shows bullish options pressure with a 58/100 conviction score, put-call volume ratio of 0.02, expected move of 13.1%, and Sharemaestro trend signal inactive.

Conviction58/100
Expected move13.1%
Put/call volume0.02
Pressure100
Speculation41
Volatility66
Trend agreement0
Open options detail
Insider activity9 / 7

9 acquisitions and 7 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment54/100

Weighted news tone is neutral across 48 relevant articles.

14 positive · 29 neutral · 5 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings30 JulLatest stored earnings date was 30 Jul 2026.
Options expected move13.1%Nearest-chain priced movement where available.
52-week drawdown-35.7%Distance below the 52-week high.
13-week volatility6.5%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher14 of 2612 weeks finished lower.
Best week+14.5%Week of 1 May.
Worst week-23.6%Week of 6 Feb.
Latest week-13.7%Week of 31 Jul.

Shape of recent returns

Strong gains6
Modest gains8
Flat weeks0
Modest losses7
Sharp losses5
Recent vol6.5%13-week weekly-return volatility.
Base vol6.9%52-week weekly-return volatility.
Up/down split28/24Count of positive and negative weeks in the 52-week window.
Average skew5.1% / -4.7%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape35/100

Trend, activity pressure, participation, and risk combine to a 35/100 tape read.

 Indicator analysis51/100

Latest 12-week confirmation: trend 0/12, activity pressure 12/12, relative leadership 6/12.

Activity pressure 0.66; No reversal markers Factors54/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 17; Small Cap Core rank 68 SVQF26/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 537.5 of 726 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options50/100

OMCL shows bullish options pressure with a 58/100 conviction score, put-call volume ratio of 0.02, expected move of 13.1%, and Sharemaestro trend signal inactive.

Bullish · Call-side pressure · Expected move 13.1% Sentiment54/100

Weighted news tone is neutral across 48 relevant articles.

Is Omnicell Inc (OMCL) a Bargain After 4.7% Drop? GF Value Says Undervalued Insiders9 / 7

9 acquisitions and 7 disposals in the latest 180-day insider tape.

 Earnings30 Jul

Latest stored earnings date was 30 Jul 2026.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202635.37 USD-13.7%40.97 USD37.29 USD0.28-15.746.1MOff
24 Jul 202641.00 USD-10.6%41.30 USD37.48 USD0.49-1.874.1MOff
17 Jul 202645.87 USD2.1%41.48 USD37.62 USD0.628.362.8MOff
10 Jul 202644.92 USD4.4%41.51 USD37.73 USD0.542.283.2MOff
3 Jul 202643.03 USD7.2%41.48 USD37.90 USD0.450.072.1MOff
26 Jun 202640.13 USD2.8%41.39 USD38.08 USD0.45-5.675.2MOff
19 Jun 202639.05 USD3.2%41.27 USD38.30 USD0.36-12.263.5MOff
12 Jun 202637.83 USD-12.0%41.17 USD38.50 USD0.38-12.754.1MOff
5 Jun 202643.00 USD-2.6%41.08 USD38.71 USD0.421.362.5MOff
29 May 202644.14 USD-0.6%40.84 USD38.90 USD0.35-0.561.8MOff
22 May 202644.41 USD3.0%40.48 USD39.09 USD0.352.982.2MOff
15 May 202643.12 USD-1.6%40.04 USD39.28 USD0.041.402.8MOff
8 May 202643.82 USD2.4%39.60 USD39.47 USD-0.302.952.6MOff
1 May 202642.80 USD14.5%39.13 USD39.65 USD-0.596.376.3MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.